Tandem Health raises $100m to turn its AI scribe into clinic software
THE SO WHAT
Tandem Health’s $100M Series B to evolve an AI scribe into full clinic software shows how fast point solutions can expand into workflow platforms once they own the clinical interaction. Healthcare IT vendors should assume AI-native entrants will try to wrap scheduling, documentation, and billing around their core agent.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureAEO startup Profound hits unicorn valuation, raises $180M Series D 7 months after last round
A $180M Series D to $1.8B less than seven months after a $96M round says investors are underwriting agentic execution outcomes, not just copilots. If your product is still a thin UI on top of someone else’s model, expect capital and customers to benchmark you against vertically integrated AEO plays like this.
Startups & VentureCarlyle’s Redett on Navigating Fundraising Supercycle
When a top PE firm talks about a “fundraising supercycle” and AI across the portfolio, it’s a signal that LP capital is being earmarked for AI-enabling plays in every sector, not just pure tech. Operators in traditional industries should expect more AI pressure from their own PE owners—both in diligence questions and in post-close value-creation plans.
Startups & VentureCarlyle’s Thomas: AI Slowdown ‘More Likely Than Not’
When a major allocator like Carlyle frames an AI slowdown as ‘more likely than not,’ it’s a warning that capital may get more selective on infra and model bets. Operators should expect tougher underwriting on AI ROI and shift from “AI story” to concrete unit economics and payback in board materials.
Startups & VentureDiscover how to take your startup from prototype to production at TechCrunch Disrupt 2026
The value here isn’t inspiration—it’s pattern-matching how Foxglove, MBRYONICS, and Bedrock Robotics handled the ugly middle from demo to deployment. If you’re going, show up with a specific bottleneck to interrogate, not a generic ‘scale’ question.